Literature DB >> 22330057

Common ocular surface disorders in patients in intensive care units.

Andre Grixti1, Maziar Sadri, Jonathan Edgar, Amit Vikram Datta.   

Abstract

Ocular surface disorders are frequently encountered in patients in Intensive Care Units (ICUs). Because of significant impairment of major organs, treatment is focused on the management of organ failures. Therefore, ophthalmological complications are frequently overlooked in this setting. To identify the types and frequencies of ocular surface disorders reported in patients in ICUs, a literature review using the keywords: Intensive Care; Eye care; ICU; ITU; Ophthalmological disorders; Eye disorders was performed. The databases of CINAHL, PUBMED, EMBASE and COCHRANE library were searched. The higher quality papers are summarized in tables with statements of methodology to clarify the level of evidence. The most prevalent ocular disorders identified in ICU patients were exposure keratopathy (3.6% to 60%), chemosis (9% to 80%), and microbial keratitis. Of the various eye care measures that have been advocated to prevent exposure keratopathy, the most effective is the application of moisture chambers or polyethylene covers. Early diagnosis and effective treatment will help to prevent microbial keratitis and visual loss. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22330057     DOI: 10.1016/j.jtos.2011.10.001

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  22 in total

1.  The Authors Reply: Ocular Ultrasonography to Detect Intracranial Hypertension in Subarachnoid Hemorrhage Patients.

Authors:  Tommaso Zoerle; Nino Stocchetti
Journal:  Neurocrit Care       Date:  2020-12       Impact factor: 3.210

2.  From bench to bedside.

Authors:  Colin L Verdant
Journal:  Crit Care       Date:  2012-07-06       Impact factor: 9.097

3.  The utilization of an ocular wound chamber on corneal epithelial wounds.

Authors:  Jennifer S McDaniel; Andrew W Holt; Elaine D Por; Elof Eriksson; Anthony J Johnson; Gina L Griffith
Journal:  Clin Ophthalmol       Date:  2018-05-14

Review 4.  [Ophthalmological care of SARS-CoV-2 positive patients in intensive care units].

Authors:  Luisa Schwarz; Christoph Lwowski; Ingo Schmack; Michael Müller; Elisabeth Adam; Kai Zacharowski; Thomas Kohnen
Journal:  Ophthalmologe       Date:  2020-07       Impact factor: 1.059

5.  Knowledge and practice patterns of Intensive Care Unit nurses towards eye care in Chhattisgarh state.

Authors:  Sonal Vyas; Ashish Mahobia; Sangeeta Bawankure
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

6.  Evaluation of the impact of intensive care support for COVID-19 on the ocular surface in a prospective cohort of 40 eyes.

Authors:  Sophie Stéphan; Florian Cohen; Isabelle Cochereau; Eric Gabison; Flore Salviat; Sophie Thevenin; Jean-Michel Devys
Journal:  Ocul Surf       Date:  2021-06-23       Impact factor: 5.033

7.  Changes of Ocular Surface and the Inflammatory Response in a Rabbit Model of Short-Term Exposure Keratopathy.

Authors:  Chun-Ting Lai; Wei-Chieng Yao; Szu-Yuan Lin; Hsin-Yu Liu; Huai-Wen Chang; Fung-Rong Hu; Wei-Li Chen
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

8.  Ocular surface disorders in intensive care unit patients.

Authors:  Tuba Berra Saritas; Banu Bozkurt; Baris Simsek; Zeynep Cakmak; Mehmet Ozdemir; Alper Yosunkaya
Journal:  ScientificWorldJournal       Date:  2013-10-29

9.  Prediction of risk and incidence of dry eye in critical patients.

Authors:  Diego Dias de Araújo; Natália Gherardi Almeida; Priscila Marinho Aleixo Silva; Nayara Souza Ribeiro; Andreza Werli-Alvarenga; Tânia Couto Machado Chianca
Journal:  Rev Lat Am Enfermagem       Date:  2016-05-17

10.  The Impact of Normal Saline on the Incidence of Exposure Keratopathy in Patients Hospitalized in Intensive Care Units.

Authors:  Zohreh Davoodabady; Korosh Rezaei; Reza Rezaei
Journal:  Iran J Nurs Midwifery Res       Date:  2018 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.